all report title image

ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET ANALYSIS

Acute Bacterial Skin And Skin Structure Infections Market, By Drug Type (Oral & Parenteral Antibiotics and Topical Antibiotics), By Infection Type (Hospital Acquired ABSSSI and Community Acquired ABSSSI), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : May 2024
  • Code : CMI1531
  • Pages :180
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Acute Bacterial Skin And Skin Structure Infections Market Size and Trends

Global acute bacterial skin and skin structure infections market is estimated to be valued at USD 3,842.5 Mn in 2024 and is expected to reach USD 5,701.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Acute Bacterial Skin And Skin Structure Infections Market Key Factors

To learn more about this report, request sample copy

There has been increase in prevalence of acute bacterial skin and skin structure infections worldwide due to changing lifestyles and environmental conditions.  The market growth is driven by increasing number of surgical procedures that require post-operative infection management. Rising geriatric population prone to such infections further drive the market growth.

 Increasing Product Launches by Key Market Players

Market players are involved in launching new drugs, and this is expected to drive growth of the global acute bacterial skin and skin structure infections market over the forecast period. For instance, on July 7, 2021, Melinta Therapeutics, a pharmaceutical company, launched its product- KIMYRSA. KIMYRSA is a lipoglycopeptide antibiotic that provide a complete course of treatment for acute bacterial skin and skin structure infections. KIMYRSA is effective in a single dose of 1200mg injection.

/p>Rising Prevalence of Skin and Soft Tissue Infections

One of the key drivers fueling growth of global acute bacterial skin and skin structure infections market is rising prevalence of various types of skin infections across both developed and developing regions. Skin and soft tissue infections include a wide range of conditions that affect the epidermis and soft tissues just below the skin. These infections can range from relatively minor and superficial infections to serious and even life-threatening deep infections. Cellulitis is one of the most common acute bacterial skin infections characterized by diffuse swelling and inflammation of the deep layers of the skin and subcutaneous tissues. According to various studies, the global incidence of cellulitis is estimated to be between 33 to 126 cases per 100,000 population per year. The rate of hospitalization due to cellulitis has also increased significantly over the last decade. Increasing prevalence of cellulitis can primarily be attributed to factors such as aging population, rising incidence of diabetes - a major risk factor, and increased microbial resistance. Similarly, wound and surgical site infections are also becoming more common globally due to growing number of surgeries and invasive procedures performed every year.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.